Fresenius Kabi expands production site in Portugal

(PresseBox) ( Bad Homburg, )
Fresenius Kabi has put two new production lines for antibiotics into operation at its plant in Santiago de Besteiros, Portugal. Representing the national government at the opening ceremony were special guests Manuel Delgado, Secretary of State of Health, and João Vasconcelos, Secretary of State of Industry.

A new 6,000-square-meter (almost 65,000-square-foot) building was erected to house the two lines, which will be used to produce penicillin for intravenous administration. About 80 new jobs are being created at the Santiago de Besteiros plant by the expansion. The total investment is about €17 million.

Dr. Michael Schönhofen, member of the Fresenius Kabi Management Board and President of the Pharmaceuticals Division, said: "This expansion is a clear commitment to our Santiago de Besteiros facility, and to Portugal. It is also a part of fulfilling our promise to provide patients worldwide with high-quality drugs."

The Fresenius Kabi plant in Santiago de Besteiros manufactures various pharmaceuticals, such as antibiotics and infusion solutions. As one of Portugal’s largest pharmaceutical production sites, it has about 600 employees.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an